OSIR

Osiris Therapeutics, Inc. News Headlines

$14.72
*  
0.20
1.38%
Get OSIR Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading OSIR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Arena Pharmaceuticals-Eisai Boost Obesity Drug Sales Force - Analyst Blog
7/11/2014 4:45:00 PM - Zacks.com

Osiris Therapeutics' Survival In Doubt After Losing 'Pass-Through' Status In 2015
7/11/2014 11:56:00 AM - Seeking Alpha

Lexicon (LXRX) Jumps: Stock Moves 7.6% Higher - Tale of the Tape
7/10/2014 9:46:00 AM - Zacks.com

BIND Therapeutics (BIND) in Focus: Stock Tumbles 10.0% - Tale of the Tape
7/7/2014 8:44:00 AM - Zacks.com

Osiris To Present At JMP Securities Conference; Webcast At 10:00 AM ET
6/25/2014 9:01:00 AM - RTT News

Merge Healthcare: Updated Research Report - Analyst Blog
6/20/2014 2:55:00 PM - Zacks.com

Illumina: Updated Research Report - Analyst Blog
6/20/2014 2:30:00 PM - Zacks.com

Geron Gains as FDA Lifts Partial Hold on Imetelstat Study - Analyst Blog
6/13/2014 1:10:00 PM - Zacks.com

Orexigen Therapeutics (OREX) in Focus: Stock Tumbles 14.7% - Tale of the Tape
6/12/2014 8:56:00 AM - Zacks.com

Biogen's Eloctate Approved in the U.S. - Analyst Blog
6/9/2014 1:50:00 PM - Zacks.com

Isis Pharma Gains on Mid-Stage Data - Analyst Blog
5/23/2014 1:50:00 PM - Zacks.com

Can the Rally in Osiris (OSIR) Shares Continue? - Tale of the Tape
5/20/2014 10:31:20 AM - Zacks.com

Increased Earnings Estimates Seen for Osiris (OSIR): Can It Move Higher? - Tale of the Tape
5/16/2014 8:47:00 AM - Zacks.com

Myriad Genetics Arm Offers New Vectra DA Data - Analyst Blog
5/15/2014 3:10:00 PM - Zacks.com

Osiris Therapeutics Q1 Loss Narrower-Than-Expected - Analyst Blog
5/13/2014 9:00:00 AM - Zacks.com

Pre-Market Earnings Report for May 13, 2014 : ECA, INSY, REN, OSIR, VTNR, AHH, IDRA, TGTX, OMEX, DCIX, ZFC, SSH
5/12/2014 4:00:02 PM - NASDAQ.com News

Commit To Purchase Osiris Therapeutics At $11, Earn 16% Annualized Using Options
5/9/2014 11:38:34 AM - BNK Invest

Osiris Therapeutics: Poised For Another Breakout
3/11/2014 2:07:00 AM - Seeking Alpha

SA PRO: Top Long And Short Ideas, Friday March 7
3/8/2014 7:30:00 AM - Seeking Alpha

Osiris Misses on Q4 Earnings - Analyst Blog
3/6/2014 10:10:01 AM - Zacks.com

Pre-Market Earnings Report for March 5, 2014 : BF/B, PETM, NAV, CSIQ, INXN, MEMP, THRM, TRK, FSS, HOV, OSIR, SBLK
3/4/2014 5:00:02 PM - NASDAQ.com News

Athersys: Two Crucial Near-Term Events
2/19/2014 11:56:00 AM - Seeking Alpha

Could PCT Be NeoStem's Breakout Star?
1/27/2014 12:06:00 PM - Seeking Alpha

Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/27/2014 8:00:01 AM - Zacks.com

Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease
1/22/2014 2:00:00 PM - Seeking Alpha